Bank of the James Financial Group is a bank holding company. Through its wholly-owned subsidiary bank, Bank of the James (the Bank), the company is engaged in lending and deposit gathering activities in Region 2000 and other markets in Central Virginia. The company conducts two principal activities: general retail and commercial banking through the Bank; and mortgage brokerage services through the Bank, a division of the Bank. In addition, the company provides securities brokerage and other investment services through BOTJ Investment, a division of the Bank, and acts as an agent for insurance and annuity products through BOTJ Insurance, Inc., a wholly-owned subsidiary of the Bank.

CVD Equipment designs, develops and manufactures a range of chemical vapor deposition, gas control and other equipment and process solutions used to develop and manufacture materials and coatings for research and industrial applications. The company operates through three segments: CVD/First Nano, which supplies chemical vapor deposition systems; SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems; and CVD Materials, which has several elements and product groups including the Tantaline corrosion resistant surface treatment, the MesoScribe direct write, the Electronic Materials for electronics and Carbon Composite products.

Home Bancshares is a bank holding company. Through its subsidiary, Centennial Bank (the Bank), the company is primarily engaged in providing a range of commercial and retail banking and related financial services to businesses, real estate developers and investors, individuals and municipalities. The Bank has branch locations in Arkansas, Florida, South Alabama and New York City. The company originates loans secured by single and multi-family real estate, residential construction and commercial buildings. The company also provides a range of deposit services, including checking, savings, money market accounts and certificates of deposit.

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

TriMas is an industrial manufacturer of products for customers in the consumer products, aerospace, industrial, petrochemical, refinery and oil and gas end markets. The company's brands include Rieke?, TriMas Aerospace?, Lamons? and Norris Cylinder? and Arrow? Engine Company. The company operates businesses in three reportable segments: Packaging, which is a designer and manufacturer of closure and dispensing systems for a range of end markets; Aerospace segment, which is comprised of TriMas Aerospace, which includes the Monogram Aerospace Fasteners, Allfast Fastening Systems and Martinic Engineering brands; Specialty Products segment, which is comprised of Norris Cylinder, Lamons and Arrow Engine Company.